ALKS
Price
$29.35
Change
-$1.18 (-3.87%)
Updated
May 23 closing price
Capitalization
4.55B
59 days until earnings call
VTRS
Price
$8.29
Change
-$0.21 (-2.47%)
Updated
May 23 closing price
Capitalization
14.18B
79 days until earnings call
Interact to see
Advertisement

ALKS vs VTRS

Header iconALKS vs VTRS Comparison
Open Charts ALKS vs VTRSBanner chart's image
Alkermes
Price$29.35
Change-$1.18 (-3.87%)
Volume$2.01M
Capitalization4.55B
Viatris
Price$8.29
Change-$0.21 (-2.47%)
Volume$9.91M
Capitalization14.18B
ALKS vs VTRS Comparison Chart
Loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALKS vs. VTRS commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Buy and VTRS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 25, 2025
Stock price -- (ALKS: $29.35 vs. VTRS: $8.29)
Brand notoriety: ALKS and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 115% vs. VTRS: 67%
Market capitalization -- ALKS: $4.55B vs. VTRS: $14.18B
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 2 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • ALKS’s FA Score: 2 green, 3 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, ALKS is a better buy in the long-term than VTRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 4 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • ALKS’s TA Score: 4 bullish, 6 bearish.
  • VTRS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ALKS and VTRS are a bad buy in the short-term.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а -6.59% price change this week, while VTRS (@Pharmaceuticals: Other) price change was -4.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.77%. For the same industry, the average monthly price growth was +10.77%, and the average quarterly price growth was +40.56%.

Reported Earning Dates

ALKS is expected to report earnings on Jul 23, 2025.

VTRS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.77% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than ALKS($4.55B). VTRS has higher P/E ratio than ALKS: VTRS (238.80) vs ALKS (8.90). ALKS YTD gains are higher at: 2.051 vs. VTRS (-31.610). VTRS has higher annual earnings (EBITDA): 3.52B vs. ALKS (519M). VTRS has more cash in the bank: 1.18B vs. ALKS (773M). ALKS has less debt than VTRS: ALKS (372M) vs VTRS (18.4B). VTRS has higher revenues than ALKS: VTRS (15.4B) vs ALKS (1.66B).
ALKSVTRSALKS / VTRS
Capitalization4.55B14.2B32%
EBITDA519M3.52B15%
Gain YTD2.051-31.610-6%
P/E Ratio8.90238.804%
Revenue1.66B15.4B11%
Total Cash773M1.18B65%
Total Debt372M18.4B2%
FUNDAMENTALS RATINGS
ALKS vs VTRS: Fundamental Ratings
ALKS
VTRS
OUTLOOK RATING
1..100
4282
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
23100
SMR RATING
1..100
3892
PRICE GROWTH RATING
1..100
5262
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (12) in the null industry is significantly better than the same rating for ALKS (99) in the Biotechnology industry. This means that VTRS’s stock grew significantly faster than ALKS’s over the last 12 months.

ALKS's Profit vs Risk Rating (23) in the Biotechnology industry is significantly better than the same rating for VTRS (100) in the null industry. This means that ALKS’s stock grew significantly faster than VTRS’s over the last 12 months.

ALKS's SMR Rating (38) in the Biotechnology industry is somewhat better than the same rating for VTRS (92) in the null industry. This means that ALKS’s stock grew somewhat faster than VTRS’s over the last 12 months.

ALKS's Price Growth Rating (52) in the Biotechnology industry is in the same range as VTRS (62) in the null industry. This means that ALKS’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is in the same range as ALKS (8) in the Biotechnology industry. This means that VTRS’s stock grew similarly to ALKS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALKSVTRS
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
58%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 9 days ago
66%
Declines
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 11 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
56%
Aroon
ODDS (%)
Bearish Trend 3 days ago
59%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
MITH.X0.0001900.000009
+4.81%
Mithril cryptocurrency
OG.X5.169317-0.077934
-1.49%
OG Fan Token cryptocurrency
ID.X0.202177-0.018356
-8.32%
SPACE ID cryptocurrency
NTRN.X0.125169-0.013572
-9.78%
Neutron cryptocurrency
STX.X0.901947-0.099040
-9.89%
Stacks cryptocurrency

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with VTRS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
-3.87%
VTRS - ALKS
35%
Loosely correlated
-1.07%
ESPR - ALKS
34%
Loosely correlated
-7.35%
DVAX - ALKS
33%
Loosely correlated
-0.20%
PAHC - ALKS
33%
Loosely correlated
-0.04%
PRGO - ALKS
33%
Loosely correlated
-1.30%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ZTS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-1.07%
ZTS - VTRS
43%
Loosely correlated
+0.38%
PBH - VTRS
42%
Loosely correlated
+1.58%
AMRX - VTRS
40%
Loosely correlated
-0.42%
ELAN - VTRS
39%
Loosely correlated
-0.08%
PAHC - VTRS
37%
Loosely correlated
-0.04%
More